Intestinal Cell News Volume 7.17 | May 14 2021

    0
    34






    ICN 7.17 | May 14 2021


    Intestinal Cell News by STEMCELL Technologies
    Vol. 7.17 – 14 May, 2021
    TOP STORY

    Dynamic Adult Tracheal Plasticity Drives Stem Cell Adaptation to Changes in Intestinal Homeostasis in Drosophila

    Researchers uncovered a previously unrecognized crosstalk between adult intestinal stem cells in Drosophila and the vasculature-like tracheal system, which was essential for intestinal regeneration.
    [Nature Cell Biology]

    Abstract

    Pathogen infection studies lacked an optimal culture system. Then she used organoids.
    PUBLICATIONSRanked by the impact factor of the journal

    Remodelling of Oxygen-Transporting Tracheoles Drives Intestinal Regeneration and Tumorigenesis in Drosophila

    Scientists showed that the adult intestinal tracheae were dynamic and responded to enteric infection, oxidative agents and tumors with increased terminal branching.
    [Nature Cell Biology]

    Abstract

    IL-1R1–Dependent Signaling Coordinates Epithelial Regeneration in Response to Intestinal Damage

    The authors reported that after distinct types of intestinal epithelial damage, IL-1R1 signaling in GREM1+ mesenchymal cells increased production of R-spondin 3, a Wnt agonist required for intestinal stem cell self-renewal.
    [Science Immunology]

    Full Article

    Critical Role of Interferons in Gastrointestinal Injury Repair

    Researchers used IFN receptor-deficient mice in a dextran sulfate sodium model of acute intestinal injury to study the contributions of type I and III interferons to the initiation, progression and resolution of acute colitis.
    [Nature Communications]

    Full Article

    Interplay between Transforming Growth Factor-β and Nur77 in Dual Regulations of Inhibitor of Differentiation 1 for Colonic Tumorigenesis

    Investigators showed that Nur77 enhanced TGFβ/Smad3-induced inhibitor of differentiation 1 (ID1) mRNA expression through hindering Smurf2-mediated Smad3 mono-ubiquitylation, resulting in ID1 upregulation.
    [Nature Communications]

    Full Article

    Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5

    The authors determined the role of LPA receptor 5 (LPA5) in regulation of intestinal epithelial barrier. Human colonic epithelial cell lines were used to determine the LPA5-mediated signaling pathways that regulate epithelial barrier.
    [Cellular and Molecular Gastroenterology and Hepatology]

    AbstractFull Article

    The Loss of SHMT2 Mediates 5-Fluorouracil Chemoresistance in Colorectal Cancer by Upregulating Autophagy

    Scientists identified serine hydroxymethyltransferase-2 (SHMT2) as a critical regulator of 5-FU chemoresistance in colorectal cancer.
    [Oncogene]

    Full Article

    G-Protein Coupled Receptor 35 (GPR35) Regulates the Colonic Epithelial Cell Response to Enterotoxigenic Bacteroides fragilis

    Researchers identified that Bacteroides fragilis toxin (BFT) signals through GPR35. Blocking GPR35 function in colon epithelial cells (CEC) using the GPR35 antagonist ML145, in conjunction with shRNA knock-down and CRISPRcas-mediated knock-out, resulted in reduced CEC-response to BFT.
    [Communications Biology]

    Full Article

    Endoplasmic Reticulum Stress Regulates the Intestinal Stem Cell State through CtBP2

    Using a novel screening method, investigators identified novel transcription factors that regulated the intestinal stem cell fate upon endoplasmic reticulum stress.
    [Scientific Reports]

    Full Article

    Indigo Enhances Wound Healing Activity of Caco-2 Cells via Activation of the Aryl Hydrocarbon Receptor

    The authors investigated the effects of indigo on wound closure in colon epithelial cells. Oral administration of indigo induced expression of Cytochrome P450 1A1 in the colon but not in the liver, suggesting that indigo stimulated AhR from the luminal side of the colon.
    [Journal of Natural Medicines]

    Abstract

    Webinar: The Promise of Organoid Medicine
    REVIEWS

    Robust Microbe Immune Recognition in the Intestinal Mucosa

    Scientists review the current knowledge on mucosal intestinal bacterial immune recognition focusing on TH17 responses and identify commonalities between intestinal pathobiont and vaccine-induced TH17 responses.
    [Genes & Immunity]

    Full Article

    INDUSTRY AND POLICY NEWS

    FDA Approves Merck’s KEYTRUDA® (Pembrolizumab) Combined with Trastuzumab and Chemotherapy as First-Line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

    Merck announced that the FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.
    [Merck (BusinessWire, Inc)]

    Press Release

    FEATURED EVENT

    Annual Canadian Society for Immunology Conference 2021

    May 31 – June 2, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Intestinal Epithelial Barrier in Autoimmune Diseases

    BioMed X Institute – Heidelberg, Germany

    Research Fellow – Intestinal Stem Cells & Gastrointestinal Diseases

    Case Western Reserve University – Cleveland, Ohio, United States

    Chair – Gastrointestinal and Pancreatic Cancer Research

    Indiana University School of Medicine – Indianapolis, Indiana, United States

    Postdoctoral Research Scientist Positions – Gastrointestinal Oncology

    Columbia University Medical Center – New York, New York, United States

    Postdoctoral Research Fellow – mRNA Translation in Cancer

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter